BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 2151711)

  • 1. The heart in congestive failure.
    Katz AM
    Cardioscience; 1990 Mar; 1(1):3-6. PubMed ID: 2151711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cardiomyopathy of overload: a hypothesis.
    Katz AM
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S68-71. PubMed ID: 1725047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms and abnormalities of contractility and relaxation in the failing heart.
    Katz AM
    Cardiologia; 1993 Dec; 38(12 Suppl 1):39-43. PubMed ID: 8020041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congestive heart failure--pathophysiology and medical treatment.
    Remme WJ
    J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S36-52. PubMed ID: 2422492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of dilated cardiomyopathy with digitalis, diuretics and vasodilators].
    Liebau G
    Herz; 1985 Jun; 10(3):138-42. PubMed ID: 2991095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of the failing heart.
    Katz AM
    Cardioscience; 1993 Dec; 4(4):199-203. PubMed ID: 8298061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cellular and molecular mechanisms in heart failure].
    Krause EG
    Z Kardiol; 1991; 80 Suppl 8():13-8. PubMed ID: 1724587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure.
    Katz AM
    N Engl J Med; 1990 Jan; 322(2):100-10. PubMed ID: 2403651
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of growth hormone in chronic heart failure: therapeutic implications.
    Volterrani M; Giustina A; Manelli F; Cicoira MA; Lorusso R; Giordano A
    Ital Heart J; 2000 Nov; 1(11):732-8. PubMed ID: 11110515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy and course of dilated cardiomyopathy].
    Hess OM; Greminger P; Maire R; Turina J; Krayenbühl HP
    Schweiz Med Wochenschr; 1985 May; 115(20):693-7. PubMed ID: 3892658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Micromethods for determining activities of energy-producing and non-energy-producing pathways in myocardial tissue.
    King JW; Kennedy FS; Hanley HG; Lierl JJ; Fowler MR; White MC
    Am J Pathol; 1986 May; 123(2):310-7. PubMed ID: 3706492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of cardiac resynchronization therapy on left ventricular function, myocardial energetics, and metabolic reserve in patients with dilated cardiomyopathy and heart failure.
    Sundell J; Engblom E; Koistinen J; Ylitalo A; Naum A; Stolen KQ; Kalliokoski R; Nekolla SG; Airaksinen KE; Bax JJ; Knuuti J
    J Am Coll Cardiol; 2004 Mar; 43(6):1027-33. PubMed ID: 15028362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nitric oxide spares myocardial oxygen consumption through attenuation of contractile response to beta-adrenergic stimulation in patients with idiopathic dilated cardiomyopathy].
    Shinke T; Takaoka H; Takeuchi M; Hata K; Kawai H; Okubo H; Kijima Y; Murata T; Yokoyama M
    J Cardiol; 2001 Feb; 37(2):119-20. PubMed ID: 11255696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognized molecular mechanisms of heart failure: approaches to treatment.
    Ceconi C; Cargnoni A; Curello S; Ferrari R
    Rev Port Cardiol; 1998 Oct; 17 Suppl 2():II79-91. PubMed ID: 9835784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in gene expression in terminal myocardial failure].
    Eschenhagen T; Mende U; Schmitz W; Scholz H
    Z Kardiol; 1992; 81 Suppl 4():33-40. PubMed ID: 1290304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Energy requirements of contraction and relaxation: implications for inotropic stimulation of the failing heart.
    Katz AM
    Basic Res Cardiol; 1989; 84 Suppl 1():47-53. PubMed ID: 2530976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From overload to failure: what happens inside the myocyte.
    Harding SE; Davia K; Davies CH; del Monte F; Money-Kyrle AR; Poole-Wilson PA
    Ann Med; 1998 Aug; 30 Suppl 1():14-23. PubMed ID: 9800879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normalization of ejection fraction and resolution of symptoms in chronic severe heart failure is possible with modern medical therapy: clinical observations in 11 patients.
    Harinstein ME; Berliner JI; Shah SJ; Taegtmeyer H; Gheorghiade M
    Am J Ther; 2008; 15(3):206-13. PubMed ID: 18496257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal intracellular calcium handling, a major cause of systolic and diastolic dysfunction in ventricular myocardium from patients with heart failure.
    Morgan JP; Erny RE; Allen PD; Grossman W; Gwathmey JK
    Circulation; 1990 Feb; 81(2 Suppl):III21-32. PubMed ID: 2153479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is heart failure an abnormality of myocardial cell growth?
    Katz AM
    Cardiology; 1990; 77(5):346-56. PubMed ID: 2073654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.